Evidence map›Paper›PMID 28751760›Full record

ArticleScientific reports2017

IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation.

Roee Dvir, Vera Paloschi, Filippo Canducci, Giacomo Dell'Antonio, Sara Racca, Rossana Caldara, Giuseppe Pantaleo, Massimo Clementi, Antonio Secchi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.International journal of molecular sciences · 2020
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Roee DvirLaboratory of Clinical Microbiology & Virology, San Raffaele Hospital IRCCS, Milan, Italy.
Vera PaloschiTransplant Unit, Department of Internal Medicine, San Raffaele Hospital IRCCS, Milan, Italy.
Filippo CanducciLaboratory of Clinical Microbiology & Virology, San Raffaele Hospital IRCCS, Milan, Italy.ORCID 0000-0002-5637-6205
Giacomo Dell'AntonioDepartment of Pathology, San Raffaele Hospital IRCCS, Milan, Italy.
Sara RaccaLaboratory of Clinical Microbiology & Virology, San Raffaele Hospital IRCCS, Milan, Italy.
Rossana CaldaraTransplant Unit, Department of Internal Medicine, San Raffaele Hospital IRCCS, Milan, Italy.
Giuseppe PantaleoUniSR-Social.Lab [Research Methods], Faculty of Psychology, Vita Salute San Raffaele University, Milan, Italy.
Massimo ClementiLaboratory of Clinical Microbiology & Virology, San Raffaele Hospital IRCCS, Milan, Italy.
Antonio SecchiTransplant Unit, Department of Internal Medicine, San Raffaele Hospital IRCCS, Milan, Italy. Secchi.antonio@hsr.it.
Vita-Salute San Raffaele University · ITUniversity of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BK virus (BKV) associated nephropathy (BKVAN) is still an important cause of allograft dysfunction after kidney transplantation (KT). Recent data have shown that the new interferon (IFN)-λ family has been ascribed antiviral properties similar to IFNα, and that the response to IFNλ in kidney is restricted to epithelial cells, suggesting that the IFNλ system evolves as specific protection of the epithelia. We aimed to test the hypothesis of correlation between a single nucleotide polymorphism (C/T dimorphism rs12979860) in the genomic region of IL28B and BKVAN, in patients after KT. Fifty kidney-transplanted patients were included as follow: Group 1 (BKV+/BKVAN+): 11 patients with active BKV- replication and biopsy-proven BKVAN; Group 2 (BKV+/BKVAN-): 22 patients with active BKV- replication but without evidence of BKVAN; Group 3 (BKV-/BKVAN-): 17 patients without evidence of BKV- replication (control group). Here we show that the C/C genotype was statistically higher in group 2 than in group 1 and BKVAN was detected significantly more frequently in patients with C/T and T/T genotypes than in patients with C/C genotype. We therefore propose IL28B polymorphism (rs12979860), as a predictor-marker to differentiate between patients with self-limited, even if persistent, BKV- reactivation and patients with a high risk of progression towards BKVAN, and to modulate the clinical management of these patients accordingly.

Indexed as

Genetic Predisposition to DiseaseAdultAgedAllelesBiomarkersBK VirusCase-Control StudiesDisease ProgressionFemaleGene ExpressionHumansInterferon LambdaInterferonsInterleukinsKidney Failure, ChronicKidney TransplantationBiomarkersInterferon Lambdainterferon-lambda, humanInterferonsInterleukins

Identifiers

PMID28751760
PMCPMC5532253
OpenAlexW2738118272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.